» COVID-19

DEA and SAMHSA Extend COVID-19 Telemedicine Flexibilities for Prescribing Controlled Medications until November 2023 while Considering Public Comments

The Drug Enforcement Administration (DEA) jointly with the Substance Abuse and Mental Health Services Administration (SAMHSA) published a temporary rule, effective May 11, 2023, extending flexibilities for the prescribing of controlled substances thr… Read More
Read More

Client Advisory: CMS Takes Action to Prepare Health Care Facilities to Respond to the Coronavirus (COVID-19) Threat

Introduction On March 4, 2020, CMS issued three new Quality, Safety, and Oversight memos intended to help ensure that America’s health care facilities are prepared to meet the threat posed by COVID-19. Two memos concerned suspension of survey activ… Read More
Read More